Penserra Capital Management LLC Clovis Oncology, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.7 - $4.76 $7,303 - $12,875	-2,705 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $1,319 - $1,885	325 Added 13.66%	2,705 $12,000
Q2 2021 Aug 12, 2021	BUY	$5.02 - $7.05 $75 - $105	15 Added 0.63%	2,380 $13,000
Q1 2021 May 13, 2021	BUY	$4.81 - $10.34 $1,635 - $3,515	340 Added 16.79%	2,365 $16,000
Q4 2020 Feb 12, 2021	BUY	$4.13 - $6.41 $8,363 - $12,980	2,025 New	2,025 $9,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.